Literature DB >> 21757383

Higher incidence and persistence of high-risk human papillomavirus infection in female sex workers compared with women attending family planning.

C González1, M Torres, J Canals, E Fernández, J Belda, M Ortiz, J Del Amo.   

Abstract

BACKGROUND: There are no data on the incidence and persistence of high-risk human papillomavirus (HR-HPV) infections in female sex workers (FSWs). We aimed to describe and compare the rates of incidence and persistence of HR-HPV infections in FSWs and women from the general population (WGP) who attended healthcare facilities between May 2003 and December 2006 in Alicante, Spain.
METHODS: Women with an established HR-HPV infection at study entry were evaluated for the analysis of HR-HPV persistence, and those testing negative for HR-HPV infection at entry were evaluated for the analysis of incidence. HR-HPV infection was determined by the Digene HC2 HR HPV DNA Test.
RESULTS: A total of 736 women - 592 WGP and 144 FSWs - were followed for a median of 16.8 months. Global incidence and persistence rates were 3.98 per 100 woman-years (95% confidence interval (CI) 2.91-5.45) and 26.81 per 100 woman-years (95% CI 20.08-35.79), respectively. In the multivariate analysis, only commercial sex work was associated with a statistically significant higher incidence (relative risk (RR) 4.72, 95% CI 2.45-9.09) and persistence (RR 1.93, 95% CI 1.08-3.46) of HR-HPV infection.
CONCLUSIONS: Our data show that FSWs have both a higher incidence and a higher persistence of HR-HPV than WGP and should be prioritized in HPV-related cancer screening programs.
Copyright © 2011 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21757383     DOI: 10.1016/j.ijid.2011.05.011

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  7 in total

1.  The Role of Chlamydia trachomatis in High-Risk Human Papillomavirus Persistence Among Female Sex Workers in Nairobi, Kenya.

Authors:  Nadja Vielot; Michael G Hudgens; Nelly Mugo; Michael Chitwa; Joshua Kimani; Jennifer Smith
Journal:  Sex Transm Dis       Date:  2015-06       Impact factor: 2.830

Review 2.  Epidemiology of HPV Genotypes among HIV Positive Women in Kenya: A Systematic Review and Meta-Analysis.

Authors:  Sonia Menon; Aibibula Wusiman; Marie Claude Boily; Mbabazi Kariisa; Hillary Mabeya; Stanley Luchters; Frode Forland; Rodolfo Rossi; Steven Callens; Davy Vanden Broeck
Journal:  PLoS One       Date:  2016-10-20       Impact factor: 3.240

3.  Human Papillomavirus infection in senegalese female sex workers.

Authors:  Halimatou Diop-Ndiaye; Kaylin Beiter; Tarik Gheit; Aissatou Sow Ndoye; Aboubacry Dramé; Sandrine McKay-Chopin; Massimo Tommasino; Cheikh Saad Bouh Boye; Bakary Sylla; Coumba Touré Kane
Journal:  Papillomavirus Res       Date:  2019-02-13

4.  Estimating incidence rates of grouped HPV types: A systematic review and comparison of the impact of different epidemiological assumptions.

Authors:  Vita W Jongen; Daniëla K van Santen; Catharina J Alberts; Maarten F Schim van der Loeff
Journal:  Papillomavirus Res       Date:  2019-10-07

5.  Human papillomavirus genotype distribution and factors associated among female sex workers in West Africa.

Authors:  Fatoumata Korika Tounkara; Ibrahima Téguété; Fernand A Guédou; Ella Goma-Matsétsé; Amadou Koné; Luc Béhanzin; Sidy Traoré; Marlène Aza-Gnandji; Bintou Keita; Julie Guenoun; François Coutlée; Michel Alary
Journal:  PLoS One       Date:  2020-11-25       Impact factor: 3.240

Review 6.  Sex Worker Health Outcomes in High-Income Countries of Varied Regulatory Environments: A Systematic Review.

Authors:  Jessica McCann; Gemma Crawford; Jonathan Hallett
Journal:  Int J Environ Res Public Health       Date:  2021-04-09       Impact factor: 3.390

7.  Human papillomavirus (HPV) types prevalence in cervical samples of female sex-workers on Curaçao.

Authors:  Desiree J Hooi; Wim G V Quint; Birgit I Lissenberg-Witte; Gemma Kenter; Herbert M Pinedo; Maurits N C de Koning; Chris J L M Meijer
Journal:  Prev Med Rep       Date:  2018-06-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.